Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jointown Pharmaceutical Group Co., Ltd. (600998.SS)
CNY5.16
-0.05 (-0.96%)
CN SHH Healthcare Medical - Distribution
Address
No. 5, Longxing West Street 430051
Wuhan, HB, CN
Wuhan, HB, CN
CEO
Wei He
Website
jztey.com
IPO
2010-11-02
ISIN CNE100000W45
Description
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY5.16
-0.05 (-0.96%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
34M
Beta
0.19
Float Shares
2.30B
Free Float %
45.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.56% | +0.42% | -7.16% | -9.26% | -2.04% | -6.25% | -7.69% | -19.46% | -24.65% | -24.88% | -31.91% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
5.16
DCF (Levered)
86.03
+1,567.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
79% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 8 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.00
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Distribution: +5.6%+6.3% ★ Q1'26: +6.6% (vs Q1'25)
-
EPS growth Medical - Distribution: +4.9%-12.0% Q1'26: -26.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Distribution: +37.6%+1.2% ★ Q1'26: -7.5% (vs Q1'25)
-
EBIT margin Medical - Distribution: +3.0%+2.7% Q1'26: +2.4% (vs Q1'25)
-
ROIC Medical - Distribution: +5.7%+4.7% Q1'26: +4.9% (vs Q1'25)
-
Share dilution Medical - Distribution: +0.0%+2.2% Q1'26: +2.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Distribution: 0.87×9.57× Q1'26: 12.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
49.59B
est: 49.38B (+0.4%)
|
61.56B
est: 61.27B (+0.5%)
|
73.94B
est: 75.55B (-2.1%)
|
87.14B
est: 87.67B (-0.6%)
|
99.50B
est: 99.17B (+0.3%)
|
110.86B
est: 110.52B (+0.3%)
|
122.41B
est: 124.67B (-1.8%)
|
140.42B
est: 138.44B (+1.4%)
|
150.14B
est: 147.95B (+1.5%)
|
151.81B
est: 153.73B (-1.2%)
|
161.39B
est: 160.06B (+0.8%)
|
170.22B
167.23B – 172.23B
+6.3% YoY
|
180.02B
173.89B – 188.02B
+5.8% YoY
|
192.83B
192.25B – 193.42B
+7.1% YoY
|
| EBITDA |
1.54B
est: 1.59B (-3.2%)
|
1.98B
est: 1.98B (+0.1%)
|
2.42B
est: 2.44B (-0.8%)
|
2.94B
est: 2.83B (+3.9%)
|
3.72B
est: 3.20B (+16.3%)
|
4.24B
est: 3.56B (+18.9%)
|
3.63B
est: 4.02B (-9.6%)
|
4.42B
est: 4.46B (-1.1%)
|
4.73B
est: 4.95B (-4.5%)
|
4.61B
est: 5.15B (-10.4%)
|
5.14B
est: 5.36B (-4.0%)
|
5.70B
5.60B – 5.76B
+6.3% YoY
|
6.02B
5.82B – 6.29B
+5.8% YoY
|
6.45B
6.43B – 6.47B
+7.1% YoY
|
| EBIT |
1.32B
est: 1.37B (-3.5%)
|
1.70B
est: 1.70B (+0.1%)
|
2.07B
est: 2.09B (-1.4%)
|
2.53B
est: 2.43B (+4.2%)
|
3.22B
est: 2.75B (+17.2%)
|
3.72B
est: 3.06B (+21.5%)
|
3.09B
est: 3.46B (-10.7%)
|
3.79B
est: 3.84B (-1.3%)
|
4.05B
est: 4.07B (-0.5%)
|
3.92B
est: 4.23B (-7.3%)
|
4.30B
est: 4.41B (-2.4%)
|
4.69B
4.60B – 4.74B
+6.3% YoY
|
4.96B
4.79B – 5.18B
+5.8% YoY
|
5.31B
5.29B – 5.33B
+7.1% YoY
|
| Net Income |
694.53M
est: 788.12M (-11.9%)
|
876.74M
est: 989.22M (-11.4%)
|
1.45B
est: 1.52B (-4.9%)
|
1.34B
est: 1.32B (+1.7%)
|
1.73B
est: 1.62B (+6.3%)
|
3.08B
est: 3.04B (+1.2%)
|
2.45B
est: 3.04B (-19.4%)
|
2.08B
est: 2.17B (-4.0%)
|
2.17B
est: 2.12B (+2.4%)
|
2.51B
est: 2.33B (+7.5%)
|
2.25B
est: 2.41B (-6.5%)
|
2.20B
2.15B – 2.56B
-8.9% YoY
|
2.63B
2.14B – 3.16B
+19.7% YoY
|
2.77B
2.29B – 3.05B
+5.4% YoY
|
| SGA |
2.17B
est: 2.36B (-8.2%)
|
2.77B
est: 2.93B (-5.4%)
|
3.69B
est: 3.62B (+1.9%)
|
4.45B
est: 4.20B (+5.9%)
|
4.88B
est: 4.75B (+2.8%)
|
5.47B
est: 5.29B (+3.3%)
|
6.01B
est: 5.97B (+0.7%)
|
6.56B
est: 6.63B (-1.0%)
|
7.11B
est: 6.20B (+14.6%)
|
7.12B
est: 6.44B (+10.5%)
|
3.14B
est: 6.71B (-53.2%)
|
7.13B
7.01B – 7.22B
+6.3% YoY
|
7.54B
7.29B – 7.88B
+5.8% YoY
|
8.08B
8.06B – 8.11B
+7.1% YoY
|
| EPS |
0.16
est: 0.16 (+1.8%)
|
0.20
est: 0.20 (+1.4%)
|
0.32
est: 0.30 (+5.6%)
|
0.27
est: 0.26 (+2.7%)
|
0.32
est: 0.32 (-1.2%)
|
0.59
est: 0.61 (-2.6%)
|
0.47
est: 0.61 (-22.4%)
|
0.40
est: 0.43 (-7.6%)
|
0.43
est: 0.41 (+4.0%)
|
0.50
est: 0.45 (+10.0%)
|
0.44
est: 0.47 (-6.4%)
|
0.47
0.42 – 0.50
-0.9% YoY
|
0.50
0.42 – 0.62
+7.8% YoY
|
0.52
0.45 – 0.60
+3.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-6.13B
OE per share TTM
-1.18
Owner's Yield
-24.39%
Maintenance CapEx ratio
22.87%
Maint CapEx / Avg PPE
6.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 39 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.21% | 93.7K | 0.54% |
| 2 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.11% | 41.7K | 0.65% |
| 3 | Xtrackers Harvest CSI A500 UCITS ETF 1D AH50.L | 0.03% | 4.9K | 0.65% |
| 4 | KraneShares ICBCCS S&P China 500 Index UCITS ETF CHIN.L | 0.03% | 22.5K | 0.55% |
| 5 | Franklin FTSE China ETF FLCH | 0.01% | 34.2K | 0.19% |
| 6 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 147.0K | 0.19% |
| 7 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 49.8K | 0.44% |
| 8 | Franklin Emerging Market Core Dividend Tilt Index ETF DIEM | 0.01% | 5.0K | 0.19% |
| 9 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 125.2K | 0.46% |
| 10 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.00% | 13.2K | 0.58% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
142.6K
Shares Outstanding
5.04B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ju Mei Yang | Deputy General Manager | — | female |
| Lei Guo | Deputy General Manager | — | female |
| Liu Zhifeng | Deputy GM & Secretary of the Board of Directors | — | male |
| Ming Quan | Deputy General Manager | — | female |
| Nie Yang | Deputy General Manager | — | male |
| Qi Bing Wang | Deputy General Manager | — | male |
| Qingsong Zhang | Deputy General Manager | — | male |
| Wei He | Vice President & Director | — | male |
| Yi Chang Liu | Business President & VC | — | male |
| Yihua Gong | GM & VC | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600998.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
